Ad is loading...
QABGX
Price
$23.57
Change
-$0.17 (-0.72%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

QABGX vs RAMHX

Header iconQABGX vs RAMHX Comparison
Open Charts QABGX vs RAMHXBanner chart's image
Federated Hermes MDT Balanced A
Price$23.57
Change-$0.17 (-0.72%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
QABGX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QABGX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QABGX is a StrongSell and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. QABGX (245M). RAMHX pays higher dividends than QABGX: RAMHX (1.84) vs QABGX (1.32). QABGX was incepted earlier than RAMHX: QABGX (19 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. QABGX (104.00). RAMHX has a lower initial minimum investment than QABGX: RAMHX (250) vs QABGX (1500). QABGX annual gain was more profitable for investors over the last year : 25.51 vs. RAMHX (20.31). RAMHX return over 5 years is better than : 32.43 vs. QABGX (28.93).
QABGXRAMHXQABGX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years10 years-
Gain YTD17.38013.582128%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets245M236B0%
Annual Yield % from dividends1.321.8472%
Returns for 1 year25.5120.31126%
Returns for 3 years-0.349.39-4%
Returns for 5 years28.9332.4389%
Returns for 10 years55.5046.74119%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings